SNY's Sarclisa Gets EU Nod for Expanded Use in Multiple Myeloma
The latest decision makes Sanofi's Sarclisa the first anti-CD38 therapy for transplant-ineligible patients with front-line ...
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug
"FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug" was originally created and published by Clinical ...
clinicaltrialsarena6 天
Ocugen doses first subject in Phase I trial of diabetic macular oedema treatment
Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular oedema (DMO) treatment.